Modulation of antitumour drug resistance: experimental laboratory data and results of clinical evaluation
- 1 September 1990
- journal article
- review article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 17 (2-3) , 197-202
- https://doi.org/10.1016/0305-7372(90)90047-j
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Toremifene: pharmacologic and pharmacokinetic basis of reversing multidrug resistance.Journal of Clinical Oncology, 1989
- Potentiation of Some Anticancer Agents by Dipyridamole against Drug-sensitive and Drug-resistant Cancer Cell LinesJapanese Journal of Cancer Research, 1989
- Effect of Glutathione on DNA Repair in Cisplatin-Resistant Human Ovarian Cancer Cell LinesJNCI Journal of the National Cancer Institute, 1989
- Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy.Journal of Clinical Oncology, 1989
- Amiodarone is more efficient than verapamil in reversing resistance to anthracyclines in tumour cellsBritish Journal of Cancer, 1987
- Pleiotropic phenotype of colchicine‐resistant CHO cells: Cross‐resistance and collateral sensitivityJournal of Cellular Physiology, 1976
- Methotrexate resistance and uptake of DDMP by L5178Y cells: Selective protection with folinic acidPublished by Elsevier ,1975
- Methotrexate toxicity: Correlation with duration of administration, plasma levels, dose and excretion patternPublished by Elsevier ,1972